Company Filing History:
Years Active: 1988-2015
Title: Innovations and Contributions of Inventor Gary J Ehrhardt
Introduction
Gary J Ehrhardt, an accomplished inventor based in Columbia, MO, has made significant strides in the field of radionuclide production and purification. With a portfolio of 15 patents, Ehrhardt's work focuses on methodologies that enhance the efficacy and safety of radiopharmaceutical applications. His innovative approaches address critical challenges in the production and purification of radioisotopes, paving the way for advancements in medical diagnostics and therapies.
Latest Patents
Among his latest contributions is the patent for a "Method and system for purifying charged radioisotopes," which offers a straightforward and cost-effective solution for eliminating metal and other impurities from radioisotope solutions. This invention also introduces a new parent/daughter generator system, facilitating the collection of daughter isotopes in concentrated forms.
Another notable patent by Ehrhardt is focused on the "Production of 186Re, 188Re, and other radionuclides via inorganic Szilard-Chalmers process." This work outlines methods for producing radionuclides that are crucial for both diagnostic and therapeutic applications in medicine. The innovative processes described involve the preparation of thin-film and powdered rhenium metal targets and oxidized target compositions, which enhance the reliability and efficiency of radionuclide production.
Career Highlights
Ehrhardt's professional journey features significant tenure at institutions like the Curators of the University of Missouri and Neorx Corporation. His involvement in these organizations has enabled him to leverage his innovative ideas in practical settings while contributing to the academic and industrial advancements in radiochemistry.
Collaborations
Throughout his career, Gary J Ehrhardt has collaborated with notable figures in the field, including Delbert E Day and Fu-Min Su. These collaborations have enriched his research endeavors, facilitating knowledge exchange and fostering innovation in the field of radionuclide studies.
Conclusion
Gary J Ehrhardt stands out as a prominent inventor whose contributions are reshaping the landscape of radiopharmaceuticals through his inventive patents and collaborative spirit. By focusing on the purification and production of critical radioisotopes, his work not only enhances medical applications but also exemplifies the power of innovation in addressing real-world challenges.